Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis

• Main Authors: Wan-Ying Lin (Author), Shih-Syuan Wang (Author), Yi-No Kang (Author), Andrea S. Porpiglia (Author), Yu Chang (Author), Chin-Hsuan Huang (Author), Ronak Bhimani (Author), Eahab Abdul-Lattif (Author), Muneeba Azmat (Author), Tsu-Hsien Wang (Author), Yu-Shiuan Lin (Author), Yu-Cheng Chang (Author), Kuan-Yu Chi (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Proton pump inhibitors (PPI), one of the most commonly prescribed medications, carry a myriad of adverse events. For colorectal cancer (CRC) patients, it still remains unclear whether the concurrent use of proton pump inhibitors (PPI) would negatively affect chemotherapy. PubMed, Medline, Embase, an...